• Username (E-mail)
  • Password
Dow 17,417 1.3%  EStoxx50 3,372 0.4%  Nikkei 17,695 0.5%  EUR 1.1343 0.1% 
Nasdaq 4,683 1.0%  FTSE100 6,811 -0.2%  Yen 117.8865 -0.4%  Oil 49.1 1.4% 
S&P500 2,021 1.0%  DAX 10,738 0.3%  GBP 1.5088 0.1%  Gold 1,261 0.2% 

United Drug share [ISIN: IE0033024807]

Realtimequote United Drug PLC in GBP

Exchange Market
3.87
Last
0
Volume
Time 11:29 AM
01/29/2015 11:29:42 AM UTC-0500
activate push

Stock Price United Drug PLC in GBP

Activate push
3.88 GBP -0.08 GBP -1.90 %
Trade Time 4:35 PM Trade Date 1/29/2015
Daily High 0.00 Open 0.00
Daily Low 0.00 Previous Close 3.88
52-week High 4.06 Volume (GBP) 0
52-week Low 3.15 Market Cap (USD) 1.47 B
52-week Perf. Exchange
The price of 3.88 GBP on the exchange London equals a price of 5.85 USD at the current exchange rate for GBP/USD.

News for United Drug PLC

More News
  • Relevant
  • All
  • Company News
No news available.

Analyst Opinions for United Drug PLC

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell

Profile United Drug PLC

Company Profile
UDG Healthcare Plc provides commercialization solutions to international healthcare companies. It provides healthcare services in Ireland, the United Kingdom, North America and Continental Europe. The company operates through three segments: Healthcare Supply Chain; Sales, Marketing and Medical; and Packaging and Specialty. The Healthcare Supply Chain segment combines all of the group's healthcare logistics based businesses. The Healthcare Supply Chain operates four business units: Pharma Wholesale, Pre-Wholesale, Medical & Scientific, and Specials. The Pharma Wholesale business unit provides delivery services of pharmaceuticals and consumer health products to retail and hospital pharmacies throughout the Republic of Ireland and Northern Ireland. The Pre-Wholesale business unit provides contract distribution and other services to pharmaceutical, consumer health, and animal health manufacturers in the Republic of Ireland and the United Kingdom. The Medical & Scientific business unit sells, distributes and supports consumables and capital equipment to healthcare providers, industry and research institutions in the Republic of Ireland, the United Kingdom and the Netherlands. The Specials business unit manufactures and distributes specially prepared products to meet specific patient prescription requirements for the retail pharmacy and hospital markets. The Sales, Marketing and Medical services segment provides contract sales outsourcing and related marketing services to healthcare manufacturers. It operates through four business units: Contract Sales Outsourcing, Medical Affairs, Events Management, and Healthcare Communications and Consultancy. The Contract Sales Outsourcing business unit provides contract sales outsourcing and sales and marketing services to pharmaceutical manufacturers in the Republic of Ireland, the United Kingdom and the U.S. The Medical Affairs business unit provides sales and marketing services, including medical affairs information, patient compliance support and clinical trials recruitment to pharmaceutical manufacturers in the United Kingdom and the U.S. The Event Management business unit provides bespoke event management and logistical services to the pharmaceutical sector. The Healthcare Communications and Consultancy business unit offers communications and consultancy services to a range of global pharmaceutical and biotechnology companies. The Packaging and Specialty segment provides outsourced packaging solutions to pharmaceutical manufacturers. It operates through four business units: Clinical Services, Europe and the U.S.; Packaging, Europe; Packaging, U. S. and Specialty. The Clinical Services, Europe and the U.S. business unit provides clinical trial materials services to the pharmaceutical and biotechnology industries. The Packaging, Europe business unit provides primary and secondary packaging solutions to the healthcare industry. The Packaging, U.S. business unit provides primary and secondary packaging solutions to the healthcare industry. The Specialty business unit provides specialty homecare services to the NHS, and the United Kingdom pharmaceutical industry and nurse-led homecare services to the Irish healthcare sector. It also provides healthcare services in the travel field, specializing in the sale and distribution of vaccines, medical information and provision of clinical services. The company was founded in 1948 and is headquartered in Dublin, Ireland.
pagehit

Login Required

Username (E-mail):
Password:
 
Login
 

You have to register to use this service. If you don't have a account already, you can register for free by clicking here.

Add or Edit Instrument

United Drug Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for United Drug

2014 2015e 2016e
Dividend 0.08 0.08 0.09
Dividend Yield in % 1.84 2.14 2.31
P/E Ratio 18.94 16.63 15.10
EPS 0.23 0.24 0.26

United Drug Key Figures

Market Cap (USD) 1.47 B
Free Float in % 98.55
Number of Shares 243.91
Cash Flow/Share in Local Currency 0.19
Asset Value/Share in Local Currency 1.76
60-Days Volatility 22.38
P/B Ratio 2.47

Base Data United Drug

Symbol
ISIN IE0033024807
Indices FTSE 250

About the Company United Drug

Country -

United Drug Historical Prices

01/28/2015
01/28/2015 06:00:00 PM UTC-0500
3.88 68,576
01/27/2015
01/27/2015 06:00:00 PM UTC-0500
3.95 84,899
01/26/2015
01/26/2015 06:00:00 PM UTC-0500
3.92 163,245
01/25/2015
01/25/2015 06:00:00 PM UTC-0500
3.95 151,429
01/22/2015
01/22/2015 06:00:00 PM UTC-0500
4.00 224,324

United Drug Peer Group

Celesio 26.13
-1.6%